DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 1.17% to $253.40 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.10% to 52,347.55 and the S&P 500 Index falling 0.40% to 7,561.67.
Biogen Inc. closed 2.91% short of its 52-week high of $261.00, which the company achieved on November 9th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.79% to $285.75, Pfizer Inc. $(PFE)$ rose 0.21% to $28.89, and AbbVie Inc. $(ABBV)$ rose 0.20% to $295.03.
Trading volume (1.0 M) remained 138,447 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 13, 2026.
Comments